Inhibition of dihydroorotate dehydrogenase (DHODH), a key enzyme in the de novo pyrimidine synthesis pathway, was recently reported to induce differentiation of diverse AML (Acute myeloid leukemia) subtypes. Inhibitors of DHODH function by blocking UMP, leading to to the rapid depletion of UMP, UDP, and UTP.
This report contains market size and forecasts of Dihydrowhey Dehydrogenase (DHODH) Inhibitor in global, including the following market information:
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market Sales, 2017-2022, 2023-2028, (Kilotons)
Global top five Dihydrowhey Dehydrogenase (DHODH) Inhibitor companies in 2021 (%)
The global Dihydrowhey Dehydrogenase (DHODH) Inhibitor market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Brequinar Protein Analogue Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Dihydrowhey Dehydrogenase (DHODH) Inhibitor include Bayer AG, Aslan Pharmaceuticals, Sanofi, DuPont, Genzyme, Agios and Pharma PTC, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dihydrowhey Dehydrogenase (DHODH) Inhibitor manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market Segment Percentages, by Type, 2021 (%)
Brequinar Protein Analogue
Inorganic Small Molecule Compounds
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market Segment Percentages, by Application, 2021 (%)
Acute Promyelocytic Leukemia (APL) Treatment
Acute Myeloid Leukemia (AML) Treatment
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Kilotons)
Global Dihydrowhey Dehydrogenase (DHODH) Inhibitor Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dihydrowhey Dehydrogenase (DHODH) Inhibitor revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Dihydrowhey Dehydrogenase (DHODH) Inhibitor revenues share in global market, 2021 (%)
Key companies Dihydrowhey Dehydrogenase (DHODH) Inhibitor sales in global market, 2017-2022 (Estimated), (Kilotons)
Key companies Dihydrowhey Dehydrogenase (DHODH) Inhibitor sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Aslan Pharmaceuticals
Sanofi
DuPont
Genzyme
Agios
Pharma PTC